Sign in

CIK 0001819133

  • Non-accelerated filer
  • Smaller reporting company

Tango Therapeutics, Inc.

Sign in to watch
Ticker
TNGX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
Phone
+1 857-320-4900
Business address
201 BROOKLINE AVENUE, SUITE 901, BOSTON, MA, 02215
Former names
BCTG Acquisition Corp.
  1. 4 Derivatives Options or other derivatives
  2. 4 Open-market sale 10% owner sold 175,000 shares at $11.60 ($2,029,703)
  3. 4 Open-market sale 10% owner sold 25,000 shares at $11.55 ($288,665)
  4. 4 Open-market sale 10% owner sold 285,000 shares at an average $9.95 ($2,835,368)
  5. 4 Open-market sale 10% owner sold 235,000 shares at an average $9.86 ($2,316,494)
  6. 4 Open-market sale 10% owner sold 50,000 shares at $9.84 ($491,950)
  7. 4 Open-market sale 10% owner sold 300,599 shares at an average $9.83 ($2,955,931)
  8. 4 Open-market sale 10% owner sold 387,740 shares at an average $9.78 ($3,793,446)
  9. 4 Open-market sale 10% owner sold 191,490 shares at $9.81 ($1,878,479)
  10. 4 Open-market sale 10% owner sold 550,171 shares at $9.79 ($5,386,339)
  11. 4 Open-market sale MVA Investors, LLC sold 234,731 shares at an average $8.76 ($2,055,314)
  12. 4 Open-market sale MVA Investors, LLC sold 140,000 shares at an average $7.04 ($985,880)
  13. 4 Grant or award Director acquired 6,250 shares (grant or award)
  14. 4 Grant or award Director acquired 6,250 shares (grant or award)
  15. 4 Planned sale Director sold 5,000 shares at $7.21 ($36,039)
  16. 4 Grant or award Director acquired 4,687 shares (grant or award)
  17. 4 Grant or award Director acquired 6,250 shares (grant or award)
  18. 4 Open-market sale MVA Investors, LLC sold 210,000 shares at an average $7.53 ($1,580,850)
  19. 4 Open-market sale 10% owner sold 162,500 shares at $12.00 ($1,950,000)
  20. 4 Open-market sale Chief Executive Officer sold 9,138 shares at an average $12.59 ($115,052)

Page 4 of 8 · 156 filings